Chongqing Rob Linka Science and Technology Co., Ltd.
FDA decision date
Mar 13, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Decision stated in the source
Substantially Equivalent
Source facts
Decision
Substantially Equivalent
Received
2023-09-26
Specialty
Physical Medicine
Decision code
SESE
Clearance type
Traditional
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.